Concerns Rise Over Trump's 100% Tariffs on Brand-Name Drugs

President Trump's announcement of 100% tariffs on foreign brand-name drugs has sparked significant concerns regarding healthcare access and costs. Experts warn that this policy could lead to substantial price increases for essential medications, impacting millions of Americans who rely on treatments for conditions like asthma and cancer. The uncertainty surrounding these tariffs highlights ongoing debates about drug pricing and healthcare accessibility.